Mecasermin Completed Phase 2 / 3 Trials for Growth Hormone Insensitivity Syndrome (GHIS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs